Clinical Trial Update: A Study of Venetoclax in Combination With Chemotherapy to Treat Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) [EARLY_Phase 1]

View source ↗

Summary

An update on a phase 1 study of venetoclax with chemotherapy for newly diagnosed Acute Lymphoblastic Leukemia, currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Venclexta (venetoclax) (venetoclax)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Acute Lymphoblastic Leukemia | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING